Sirolimus

NDC 67877-746 · Ascend Laboratories, LLC

Generic nameSirolimus

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)SIROLIMUS

Strength.5 mg/1

Pharmacologic classDecreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]

Marketing categoryANDA

Packages

67877-746-01 — 100 TABLET, FILM COATED in 1 BOTTLE (67877-746-01)

67877-746-05 — 500 TABLET, FILM COATED in 1 BOTTLE (67877-746-05)

67877-746-30 — 30 TABLET, FILM COATED in 1 BOTTLE (67877-746-30)

67877-746-38 — 100 BLISTER PACK in 1 CARTON (67877-746-38) / 10 TABLET, FILM COATED in 1 BLISTER PACK (67877-746-33)

Billed under HCPCS

J7520 — Sirolimus, oral, 1 mg Medicare Part B payment limit (ASP + 6%): $0.74

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

59762-1001 — SIROLIMUS, 59762-1002 — SIROLIMUS, 59762-1003 — SIROLIMUS, 59762-1205 — sirolimus, 60505-6197 — SIROLIMUS, 60687-902 — sirolimus, 65841-771 — sirolimus, 65841-772 — sirolimus, 65841-773 — sirolimus, 66689-347 — Sirolimus, 67877-747 — Sirolimus, 67877-748 — Sirolimus, 68084-915 — Sirolimus, 68382-351 — sirolimus, 68382-352 — sirolimus, 68382-520 — sirolimus, 68462-682 — sirolimus, 68462-683 — sirolimus, 68462-684 — sirolimus, 69238-1594 — SIrolimus, +18 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.